Skip to content
Search

Latest Stories

Boots partners with LIVI to strengthen its digital pharmacy services

Boots UK on Thursday (16) announced a new partnership with digital healthcare provider LIVI to strengthen its digital pharmacy services.

The existing Boots UK and LIVI collaboration of in-store services is expanding as trial of a new online GP and pharmacy video consultation service begins.


The trial has been brought forward to assist patients isolating due to the Covid-19 pandemic.

Richard Bradley, Director of Pharmacy for Boots UK, said: “With millions of patients self-isolating at home – particularly the elderly or those with underlying health conditions – access to expert health advice without having travel to a pharmacy or GP surgery is even more crucial.

“We are pleased to work with innovators like LIVI to continue transforming online and high street access to healthcare advice, medical services and medicines.”

The companies are working together through approved and regulated routes to trial how patients could remotely access a Boots pharmacist via the LIVI app, to get general health advice and to have a conversation face-to-face about their own prescription medications.

This service has the potential to help reduce pressure on the NHS, ensuring that customers maintain simple and safe access to healthcare whilst at home.

The partnership will also see a future expansion of the successful in-store pilot to several new Boots UK stores – the majority of which will deliver NHS commissioned services – in high street locations throughout the country.

Juliet Bauer, UK Managing Director, LIVI, said: “Boots UK shares our ethos that the health system should be responsive to the needs of patients. By tapping into our digital health tech, millions of Boots UK customers will be able to access a more responsive and flexible health service.”

The long-term agreement follows the successful pilot programme in two Boots stores from October 2019. These stores will offer the LIVI video GP service via a tablet in-store, as well as a range of diagnostic tools, such as blood pressure monitoring.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less